Position in SCYX
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$35,286
+$4,963 QoQ
Shares Held
4,810
-19.8% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SCYX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026LPL Financial LLC holds $154,257,402 across 47 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
368,249 | $26,462,373 | |
| 2 | HLN |
Haleon plc
|
2,036,156 | $18,997,335 | |
| 3 | PRGO |
PERRIGO Co plc
|
1,431,267 | $14,870,864 | |
| 4 | VTRS |
Viatris Inc
|
678,057 | $10,767,545 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
432,525 | $10,644,440 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
62,420 | $10,520,266 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
258,667 | $8,967,984 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
555,228 | $8,900,304 |
All Filings in SCYX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $35,286 | 38,480 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $30,323 | 47,980 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $41,333 | 53,680 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $42,781 | 63,380 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $59,861 | 62,880 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $75,479 | 62,380 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $112,539 | 75,530 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $144,960 | 72,480 | Shares | Sole | 2024-08-07 | |
| 2020-06-30 | $20,277 | 27,000 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $28,897 | 37,000 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||